COMMUNIQUÉS West-GlobeNewswire

Shareholders Turn Down Tender Offer to Take BioCanCell Private

28/12/2017 - 15:23

JERUSALEM, Dec. 28, 2017 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE: BICL ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat cancer, [...]

Tower One Intends to Apply for Warrant Price Reduction

28/12/2017 - 15:00

VANCOUVER, British Columbia, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) announced today that it intends to apply for a warrant [...]

Innovate Biopharmaceuticals’ Dose Response Data for Larazotide Acetate Demonstrating Its Unique Mechanism of Action and Applications in Diseases Caused by Increased Intestinal Permeability

28/12/2017 - 15:00

RALEIGH, N.C., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc . (“Innovate”), a clinical stage biotechnology company focused on developing novel medicines for autoimmune and inflammatory disorders, [...]

Predictive Technology Group, Inc. (PRED) Announces Issuance of U.S. Patent for Method of Treating Endometriosis

28/12/2017 - 15:00

SALT LAKE CITY, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK:PRED), a life sciences technology holding company, announced today the issuance of U.S. patent 9,840,738 directed to treating [...]

Adverum Biotechnologies Doses First Patient in the ADVANCE Phase 1/2 Clinical Trial of ADVM-043 for A1AT Deficiency

28/12/2017 - 15:00

-- Company Expects to Report Preliminary Data in the Second Half of 2018 -- MENLO PARK, Calif., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a clinical-stage gene therapy company [...]

Tauriga Sciences, Inc. Confirms that 10,000 Units of “HerMan” Product Inventory Have Been Delivered by Manufacturer

28/12/2017 - 14:51

NEW YORK, NY, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building business through the development, distribution, and licensing of proprietary [...]

Auris Medical News Release - Auris Medical to Provide Update on Its AM-111 Hearing Loss Program on Thursday, January 4, 2018

28/12/2017 - 14:30

Zug, Switzerland, Dec. 28, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that [...]

Onconova Therapeutics to Present at Biotech Showcase in January

28/12/2017 - 14:30

NEWTOWN, Pa., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary [...]

Acology Closes Strong ‘17, Readies for Big ‘18

28/12/2017 - 14:30

CORONA, Calif., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Acology Inc. (OTCMKTS:ACOL) announced today that they have completed talks with EZ Health Solutions and will begin manufacturing new CBD products early next year. Pre- [...]

Quotient Limited to Participate in the 36th Annual J.P. Morgan Healthcare Conference

28/12/2017 - 14:00

JERSEY, Channel Islands, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT ), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, [...]

BioSig Technologies to Present at Digital Medicine & Medtech Showcase at Biotech Showcase

28/12/2017 - 14:00

Santa Monica, CA, Dec. 28, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]

Momenta Pharmaceuticals to Webcast Presentation at the 36th Annual J. P. Morgan Healthcare Conference

28/12/2017 - 14:00

CAMBRIDGE, Mass., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that [...]

PetVivo Hires Randy Wenthold to Replace David Masters as Chief Technical Officer

28/12/2017 - 14:00

(All Press Releases Will Be Available for Viewing on Facebook or the Web at www.petvivo.com ) PETVIVO HIRES MR. RANDY WENTHOLD AS CSO MINNEAPOLIS, Dec. 28, 2017 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCMARKETS: [...]

Cellular Biomedicine Group Announces Closing of $14.5 Million Private Placement Offering

28/12/2017 - 13:30

SHANGHAI, China and CUPERTINO, Calif., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG ) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of [...]

Inspire continues expansion of partnerships with nonprofit advocacy organizations

28/12/2017 - 13:00

ARLINGTON, Va., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Inspire, the leading healthcare social network, has expanded its reach with new partnerships with nonprofit patient advocacy organizations. Inspire heads into 2018 with [...]

Cancer Genetics Receives Non-Dilutive Funding of $1.1 Million through New Jersey Technology Business Tax Certificate Transfer (NOL) Program

28/12/2017 - 13:00

RUTHERFORD, N.J., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX ), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced that the company [...]

GW Pharmaceuticals Announces Acceptance of NDA Filing for Epidiolex® (cannabidiol) in the treatment of Lennox-Gastaut syndrome and Dravet syndrome

28/12/2017 - 13:00

LONDON and CARLSBAD, Calif., Dec. 28, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel [...]

Veritas Pharma Subsidiary Receives Health Canada Dealer Licence

28/12/2017 - 09:05

VANCOUVER, British Columbia, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) announces that Health Canada has issued its research and [...]

The Financial Calendar of AS Olainfarm for 2018

28/12/2017 - 07:50

Olaine, 2017-12-28 07:50 CET (GLOBE NEWSWIRE) -- unaudited financial statements for 2017 on 28 February 2018; unaudited interim financial statement for 3 months of 2018 on May 31, 2018; unaudited interim financial [...]